It has been hypothesized that elevated plasma Homocysteine (Hcy) plays a role in the pathogenesis of Alzheimer's disease (AD) and age-related cognitive decline. The mechanism of Hcy neurotoxicity in the brain is controversial as well Hcy is a ligand of NMDA receptor. Memantine, an uncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptors approved for the treatment of moderate to severe Alzheimer's disease.
Hyperhomocysteinemia and has been known as a risk factor in cardiovascular and neurodegenerative disease (1).
Hyperhomocysteinemia is a risk factor for stroke, Alzheimer's and Parkinson's diseases, schizophrenia, depression, renal diseases, leukemia and diabetes (2, 3) . Homocysteine (Hcy) is a sulfurcontaining amino acid derived from methionine.
Moderate to severe hyperhomocysteinemia can be caused by deficiencies of folate or vitamin B12, genetic defects in the metabolism of methionine, certain drugs and renal disease (4) . Memantine, a drug used clinically for the treatment of moderate to severe Alzheimer's disease is a moderate-affinity, uncompetitive antagonist of NMDA receptors (8, 9) . It has been shown that Memantine-treated rats are less neurodegeneration induced by Ab1-40 injections into the hippocampus (10) . HCl (10mg/kg) was injected (i.p.) prior to Hcy injection.
Materials and Methods

Drugs and
Intra hippocampus injection
The rats were anaesthetized with Ketamin- 
Statistics
The Bax, Bcl-2, Caspase3 immunostaining, were determined at each control, homocysteine, and Memantine-homocysteine groups by using the mean scales of Bax and Bcl-2 in the same animal.
All of the data are presented as means ± standard error of the mean (SEM) and analyzed by t tests or one-way analysis of variance as appropriate using Graph Pad Prism Software (version 5). p<0.05 was considered statistically significant.
Results
Effects of Homocysteine on Bax and Bcl-2 Protein Levels
To determine whether Hcy leads to changes in Bcl-2 family protein levels, we examined the Memantine pre-treatment in Hcy groups (Fig. 2, 3, 4) .
Effects of Homocysteine on Activated Caspase 3 Immunostaining
To confirm whether the increase of Bax/Bcl-2 ratio does lead to the activation of apoptotic cascade, we analyzed the immunostaining of cleaved Caspase 3 in all of the experimental groups.
Rabbit monoclonal antibody used in this study detects cleaved Caspase 3, the large active fragment that is derived from inactive full-length Caspase 3.
As shown in Figure 5a , the degree of cleaved Caspase 3 immunostaining was low in control groups. But as expected according to the raised Bax/Bcl-2 ratio in Hcy-treated groups, active Caspase-3 immunoreactivity significantly increased as a result of Hcy toxicity (F2, 15=50.24, P<0.001) (Fig. 5b, c) . Memantine pretreatment did not decrease Caspase 3 immunoreactivity significantly (Fig. 6 ).
Discussion
The aim of this study was to investigate the neurotoxicity of Hcy on hippocampus cells. Hcy (0.5 µmol) was directly injected in rat hippocampus and programmed cell death (apoptosis) was analyzed by Immunohistochemistry method.
Three markers: Bax, Bcl-2 and Caspase 3 were detected and Bax/Bcl-2 ratio was also measured. 
